Ernexa Therapeutics Inc.
- ERNA
- NASDAQ
- Biotechnology
- Stem Cell Therapy
- Oncology/Autoimmune Biotech
$2.09
Today −3.69%Quote Oct 16, 2026, 08:00 PM UTC
−44.41%over the last month
Max drawdown −47.2%From 1-month high −47.2%3 months −61.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$3.4M
Quote Oct 16
Next earnings
Nov 6
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.99
4.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ERNAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
5